Biopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders.

You would expect a building where vinegar is made to have a sour smell, highly pungent, perhaps with a whiff of apple. World Technology Ingredients (WTI) smells nothing like this.

It has been a little more than two years since I last summarized the topics that are keeping CEOs up at night, either thinking about challenges their organizations face, or opportunities and innovations that should be explored.

Gathered inside a small shed in the midst of a peaceful meadow, my colleagues and I are about to flip the switch to start a seemingly mundane procedure: using a motor to shake a wooden board.

Have you heard of a media company called T-Series? Chances are, you probably haven’t. Gulshan Kumar, whose résumé up to 1983 read, “Fruit juice seller, streets of New Delhi,” founded it that year.

It’s generally accepted that large organizations, for a host of structural and cultural reasons, are at a disadvantage when it comes to innovation. Less agreed upon is why their employees outside of R&D should care.

MIT researchers have devised a novel circuit design that enables precise control of computing with magnetic waves—with no electricity needed.

I recently visited the Key West home of famed writer Ernest Hemingway. The descendants of Hemingway’s many six-toed cats still live on the grounds and join visitors as a part of their tour. “A cat has absolute emotional honesty,” wrote Hemingway.

Today, the survival of many organizations depends on their plans to leverage cutting-edge artificial intelligence (AI) technologies to transform their workplaces into augmented environments.

Having trouble paying attention? MIT neuroscientists may have a solution for you: Turn down your alpha brain waves.